Prognostic factors for overall survival in patients with advanced NSCLC – data from the clinical registry on lung cancer (TLK). 6. Juni 2014 von Verschuer, U., Tessen, H.W., Eggert, J., Neise, M., Frank, M., Jänicke, M., Spring, L., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(V701), 227. doi:10.1159/000368945 Abstract Effectiveness of treatments for tumor-(therapy-) associated anemia in routine practice – data from the clinical tumor anemia registry (TAR). Steinmetz, T., Köhler, A., Groschek, M., Koenigsmann, M., Vogt, M., Frank, M., Jänicke, M., 2014. Oncol ResTreat 37 (suppl 5)(P534), 172. doi:10.1159/000368945… Weiterlesen SWITCH: a randomized sequential open-label study to evaluate efficacy and safety of sorafenib (SO) / sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC). Weikersthal, L.F. von, Goebell, P.J., de Santis, M. de, Lerchenmüller, C., Zimmermann, U., Bos, M.M.E.M., Freier, W., Schirrmacher-Memmel, S., Staehler, M.D., Pahernik, S., Los, M.,… Weiterlesen